Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-03-12 @ 2:43 AM
Study NCT ID:
NCT00660335
Status:
COMPLETED
Last Update Posted:
2009-12-03
First Post:
2008-04-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas
Sponsor:
Repligen Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RG1068-16
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Melinda Livingstone
Old Organization:
Repligen Corporation